This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28:3243–56.
Fountoulakis KN, Gonda X, Andreoulakis E, Fokas K, Iacovides A. No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study. J Psychiatr Res. 2013;47:1984–90.
Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379:2063–71.
Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, et al. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. CNS Spectrums. 2021;26:562–86.
Fountoulakis KN, Veroniki AA, Siamouli M, Moller HJ. No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis. Ann Gen Psychiatry. 2013;12:26.
Fountoulakis KN, Moller HJ. Are antidepressants clinically useful? Conclusion of a decade of debate. World Psychiatry. 2014;13:201–2.
Fountoulakis KN. Culturally sanctioned “scientific pluralism” opens the backdoor for the supernatural in Psychiatry. Acta Psychiatr Scand. 2022;145:109–10.
Fountoulakis KN. Should denialism of mental illness and its treatment be included among conspiracy theories? Eur Arch Psychiatry Clin Neurosci. 2021;271:591–3.
Fountoulakis KN, Tohen M. Interpreting the findings of a meta-analysis of psychosocial interventions in bipolar disorder. JAMA Psychiatry. 2021;78:447–8.
Cuijpers P, Karyotaki E, Andersson G, Li J, Mergl R, Hegerl U. The effects of blinding on the outcomes of psychotherapy and pharmacotherapy for adult depression: a meta-analysis. Eur Psychiatry. 2015;30:685–93.
Author information
Authors and Affiliations
Contributions
KNF conceived the idea and wrote the first draft, EMT contributed to revisions of the manuscript and both authors to the final text.
Corresponding author
Ethics declarations
Competing interests
Both authors have received honoraria for speeches and support for travel and accommodation to participate in congresses by the pharma industry, including Jannssen, Lilly, Bristol-Myers, Astra-Zeneca, and others.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fountoulakis, K.N., Tsapakis, E.M. Neither serotonin disorder is at the core of depression nor dopamine at the core of schizophrenia; still these are biologically based mental disorders. Mol Psychiatry 29, 198–199 (2024). https://doi.org/10.1038/s41380-024-02458-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-024-02458-z
This article is cited by
-
Difficult lives explain depression better than broken brains
Molecular Psychiatry (2024)